{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:47:00Z","timestamp":1791190020554,"version":"4.1.0"},"reference-count":71,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T00:00:00Z","timestamp":1219881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Systemic therapy of severe atopic dermatitis (AD) is difficult in some cases, because the use of immunosuppressive agents such as cyclosporine A, mofetil mycophenolate, tacrolimus, and azathioprine is limited by adverse reactions or contraindications. Recent reports suggest a helpful role for biologics, methotrexate, anti\u2010IgE antibodies, and immunotherapy. We review the modes of action, as well as advantages and disadvantages of current and new systemic therapeutic options for severe AD.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2008.06834.x","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T18:45:23Z","timestamp":1223750723000},"page":"205-219","source":"Crossref","is-referenced-by-count":23,"title":["Systemic therapeutic options for severe atopic dermatitis"],"prefix":"10.1111","volume":"7","author":[{"given":"Caroline","family":"Bu\u00dfmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalija","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,2,20]]},"reference":[{"key":"e_1_2_18_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.03.045"},{"key":"e_1_2_18_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70390-8"},{"key":"e_1_2_18_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s3013.x"},{"key":"e_1_2_18_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02271.x"},{"key":"e_1_2_18_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000090246"},{"key":"e_1_2_18_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.1999.00460.x"},{"key":"e_1_2_18_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00963.x"},{"key":"e_1_2_18_9_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2001.056006512.x"},{"key":"e_1_2_18_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00373427"},{"key":"e_1_2_18_11_2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2340\/00015555754649","article-title":"Topical an\u2010timycotic treatment of atopic dermatitis in the head\/neck area. A double\u2010blind randomised study","volume":"75","author":"Broberg A","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_18_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000024346"},{"key":"e_1_2_18_13_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.1999.00958.x"},{"key":"e_1_2_18_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70288-Q"},{"key":"e_1_2_18_15_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.123303"},{"key":"e_1_2_18_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90281-9"},{"key":"e_1_2_18_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.d01-1146.x"},{"key":"e_1_2_18_18_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3038.2001.012004216.x"},{"key":"e_1_2_18_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90134-B"},{"key":"e_1_2_18_20_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archderm.1987.01660260034008","article-title":"Efficacy of low\u2010dose cyclosporine in severe atopic skin disease","volume":"123","author":"Van Joost T","year":"1987","journal-title":"Arch Dermatol"},{"key":"e_1_2_18_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.02023.x"},{"key":"e_1_2_18_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb00704.x"},{"key":"e_1_2_18_23_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.1509"},{"key":"e_1_2_18_24_2","first-page":"870","article-title":"Mycophenolate mofetil is effective in the treatment of atopic dermatitis","volume":"137","author":"Grundmann\u2010Kollmann M","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_18_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70147-6"},{"key":"e_1_2_18_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04108.x"},{"key":"e_1_2_18_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02952.x"},{"key":"e_1_2_18_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03914.x"},{"key":"e_1_2_18_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03667.x"},{"key":"e_1_2_18_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03623.x"},{"key":"e_1_2_18_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2007.00135.x"},{"key":"e_1_2_18_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70446-9"},{"key":"e_1_2_18_33_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.137"},{"key":"e_1_2_18_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07686.x"},{"key":"e_1_2_18_35_2","first-page":"155","article-title":"Methotrexate for the treatment of adult atopic dermatitis","volume":"16","author":"Goujon C","year":"2006","journal-title":"Eur J Dermatol"},{"key":"e_1_2_18_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04922.x"},{"key":"e_1_2_18_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68340-2"},{"key":"e_1_2_18_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050161"},{"key":"e_1_2_18_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4857-7_53"},{"key":"e_1_2_18_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04989.x"},{"key":"e_1_2_18_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0960.2002.00573.x"},{"key":"e_1_2_18_42_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D36CG6S9T4","article-title":"Severe atopic dermatitis and leflunomide: first clinical experience and highlights of pertinent experimental data","volume":"12","author":"Wozel G","year":"2006","journal-title":"Dermatol Online J"},{"key":"e_1_2_18_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0007-0963.2003.05846.x"},{"key":"e_1_2_18_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.5.555"},{"key":"e_1_2_18_45_2","first-page":"994","article-title":"Successful treatment of severe refractory atopic dermatitis with efalizumab","volume":"5","author":"Farshidi A","year":"2006","journal-title":"J Drugs Der-matol"},{"key":"e_1_2_18_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.025"},{"key":"e_1_2_18_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.031"},{"key":"e_1_2_18_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701169"},{"key":"e_1_2_18_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04222.x"},{"key":"e_1_2_18_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.11.022"},{"key":"e_1_2_18_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.03.013"},{"key":"e_1_2_18_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00791.x"},{"key":"e_1_2_18_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.003"},{"key":"e_1_2_18_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.05.035"},{"key":"e_1_2_18_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.08.060"},{"key":"e_1_2_18_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.05.035"},{"key":"e_1_2_18_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.09.030"},{"key":"e_1_2_18_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.02.014"},{"key":"e_1_2_18_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.12.045"},{"key":"e_1_2_18_60_2","first-page":"38","article-title":"Success of omalizumab as monotherapy in adult atopic dermatitis: case report and discussion of the high\u2010affinity immunoglobulin E receptor, FcepsilonRI","volume":"80","author":"Forman SB","year":"2007","journal-title":"Cutis"},{"key":"e_1_2_18_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.11.016"},{"key":"e_1_2_18_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.07.054"},{"key":"e_1_2_18_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.00974.x"},{"key":"e_1_2_18_64_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03377.x"},{"issue":"1","key":"e_1_2_18_65_2","first-page":"61","article-title":"Intravenous immune globulin: an alternative therapy in steroid\u2010dependent allergic diseases","volume":"104","author":"Gelfand EW","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_18_66_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550310020549"},{"key":"e_1_2_18_67_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04833.x"},{"key":"e_1_2_18_68_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.1999.14.1.63"},{"key":"e_1_2_18_69_2","doi-asserted-by":"publisher","DOI":"10.1159\/000104265"},{"key":"e_1_2_18_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00370718"},{"key":"e_1_2_18_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70440-8"},{"key":"e_1_2_18_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70122-7"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2008.06834.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2008.06834.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T06:58:12Z","timestamp":1697439492000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2008.06834.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,20]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1610-0387.2008.06834.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2008.06834.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,20]]}}}